By 
A security guard stands in a greenhouse of Tilray medical cannabis producer’s European production site in Cantanhede, on April 24, 2018.
Patricia De Melo Moreira | AFP | Getty Images
The merger between cannabis companies Aphria and Tilray officially closed this week, and the resulting company is set up to be a major player in multiple countries as legal weed gains steam, according to Jefferies.
Analyst Owen Bennett upgraded Tilray to buy from underperform on Friday, saying in a note to clients that the strengths of the two companies complement one another and position the new company for success in Europe and North America.
Comments